Pancreatic Cancer: The Hunt to Catch a Silent Killer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
The A,B,C's of Identifying Melanoma
Jennifer Caudle, DO
PeerKnowing your Patient's Melanoma Risk Factors
Jennifer Caudle, DO
PeerBrian P. McDonough, MD, FAAFP
PeerFDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
The Financial Burden of Cancer: Report from the American Cancer Society
Brian P. McDonough, MD, FAAFP
PeerFDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)